✦ LIBER ✦

Synthesis of a 2-benzazepine analog of a potent, nonpeptide GPIIb/IIIa antagonist

✍ Scribed by William H. Miller; Kenneth A. Newlander; Drake S. Eggleston; R.Curtis Haltiwanger

Book ID: 103399775
Publisher: Elsevier Science
Year: 1995
Tongue: French
Weight: 217 KB
Volume: 36
Category: Article
ISSN: 0040-4039
DOI: 10.1016/0040-4039(94)02273-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A new synthesis of the GPIIb/IIIa recept

A new synthesis of the GPIIb/IIIa receptor antagonist SB-214857-A

✍ Ian P Andrews; Richard J Atkins; Neil F Badham; Richard K Bellingham; Gary F Bre 📂 Article 📅 2001 🏛 Elsevier Science 🌐 French ⚖ 74 KB

Pharmacodynamics and pharmacokinetics of

Pharmacodynamics and pharmacokinetics of YM128, a GPIIb/IIIa antagonist prodrug

✍ Ken-ichi Suzuki; Yumiko Moritani; Nami Hisamichi; Masato Ichihara; Seijiro Akama 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 287 KB

Prodrug and Analog Approaches to Improvi

Prodrug and Analog Approaches to Improving the Intestinal Absorption of a Cyclic Peptide, GPIIb/IIIa Receptor Antagonist

✍ Hiroshi Saitoh; Bruce J. Aungst 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 424 KB

ChemInform Abstract: The Enantiospecific

ChemInform Abstract: The Enantiospecific Synthesis of an Isoxazoline. A RGD Mimic Platelet GPIIb/IIIa Antagonist.

✍ L. ZHANG; J. C. CHUNG; T. D. COSTELLO; I. VALVIS; P. MA; S. KAUFFMAN; R. WARD 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 1 views

The Enantiospecific Synthesis of an Isoxazoline. A RGD Mimic Platelet GPIIb/IIIa Antagonist. -The crystalline compound (VI), is synthesized on a multikilogram scale in 8 steps in 37% overall yield and ¿99.

ChemInform Abstract: Nonpeptide GPIIB/II

ChemInform Abstract: Nonpeptide GPIIB/IIIA Inhibitors. Part 10. Centrally Constrained alpha- Sulfonamides are Potent Inhibitors of Platelet Aggregation.

✍ M. S. EGBERTSON; G. D. HARTMAN; R. J. GOULD; B. BEDNAR; R. A. BEDNAR; J. J. COOK 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 1 views

Enantiospecific synthesis of SB 214857,

Enantiospecific synthesis of SB 214857, a potent, orally active, nonpeptide fibrinogen receptor antagonist

✍ William H. Miller; Thomas W. Ku; Fadia E. Ali; William E. Bondinell; Raul R. Cal 📂 Article 📅 1995 🏛 Elsevier Science 🌐 French ⚖ 259 KB